However, because of the retrospective study design and the potential influence of age differences, dietary management, standard treatment, and renal dysfunction, these findings should be considered hypothesis-generating rather than definitive
10.1016/j.regpep.2012.12.007 7 BecejacT.CesarecV.DrmicD.HirslD.MadzaracG.DjakovicZ.et al (2018)
That research does not equal approval for injection
Orforglipron (LY3502970), a novel, oral non-peptide glucagon-like peptide-1 receptor agonist: a phase 1b, multicentre, blinded, placebo-controlled, randomized, multiple-ascending-dose study in people with type 2 diabetes
What are the different types of antioxidant supplements
This method is common for therapies like TRT, NAD+, and vitamin supplementation